Global Fund to Fight AIDS, Tuberculosis and Malaria
Current understanding
The Global Fund is a Geneva-based multilateral financing institution that channels donor contributions into HIV, TB, and malaria programs, with the U.S. as a major contributor via both State Department and USAID. State Department obligations flow under letter agreements and can fund product purchases through Wambo.org, the Global Fund’s online procurement platform.
Evidence log
- 2025-11-25 — State · THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) — $38.3M (CHE): State obligated $38.3M to the Global Fund (place of performance Switzerland) to procure Lenacapavir for PrEP for DOS/GHSD-financed beneficiaries in PEPFAR-supported countries, illustrating use of the Global Fund channel for a specific HIV prevention commodity buy. (novelty: 3)
- 2026-05-12 — State · THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) — $260.5M (CHE): cross-connection with pepfar: State’s HIV-focused Global Fund contribution complements PEPFAR bilateral programming as parallel U.S. channels for HIV response. (novelty: 3)
Open questions
Related
Contributing findings
State · THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) — $260.5M (CHE)
12-may-2026
novelty 3
per-area 3
introduces
State · THE GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS AND MALARIA (THE GLOBAL FUND) — $38.3M (CHE)
25-nov-2025
novelty 3
per-area 3
strengthens